concept

SLEEP

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SLEEP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

158Connections
15Hypotheses
2Analyses
48Outgoing
50Incoming
16Experiments
2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameSLEEP
Key Genes/ProteinsALZHEIMER DISEASE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

REM Sleep Behavior Disorder (RBD) - Diagnostic Marker for Synucleinopathies

diagnostic · 1866 words

Pathway Diagram

graph TD
    SLEEP["SLEEP"]
    SLEEP -->|"activates"| Glymphatic_Pathway["Glymphatic Pathway"]
    SLEEP -->|"modulates"| CIRCADIAN_RHYTHM["CIRCADIAN RHYTHM"]
    SLEEP -->|"modulates"| Circadian_Rhythm["Circadian Rhythm"]
    SLEEP -->|"contributes to"| Healthy_Brain_Aging["Healthy Brain Aging"]
    SLEEP -->|"regulates"| HSPA1A["HSPA1A"]
    GABAergic_Interneurons["GABAergic Interneurons"] -->|"regulates"| SLEEP
    Circadian_Clocks["Circadian Clocks"] -->|"regulates"| SLEEP
    Caffeine["Caffeine"] -->|"modulates"| SLEEP
    Serotonin["Serotonin"] -->|"regulates"| SLEEP
    HSPA1A -->|"regulates"| SLEEP
    ADENOSINE_RECEPTORS["ADENOSINE RECEPTORS"] -->|"regulates"| SLEEP
    n_5_HT["5-HT"] -->|"modulates"| SLEEP
    MTNR1B["MTNR1B"] -->|"regulates"| SLEEP

Outgoing (48)

TargetRelationTypeStr
interstitial spaceassociated_withprocess0.95
β-amyloidassociated_withprotein0.95
Metabolite Clearancepromotesprocess0.95
glymphatic_clearanceactivatesmechanism0.95
Waste Product Removalpromotesprocess0.92

Incoming (110)

SourceRelationTypeStr
34902819influencespaper0.90
Circadian Clocksregulatesprocess0.90
GABAergic Interneuronsregulatescell_type0.90
Caffeinemodulatescompound0.90
33268891promotepaper0.90

Targeting Hypotheses (15)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic 0.780 neurodegeneration What is the therapeutic window between t
Night-phase orexin receptor antagonism rescues AD by restori 0.758 neurodegeneration Orexin-A manipulation in AD cognition an
Sleep Spindle-Synaptic Plasticity Enhancement 0.721 neurodegeneration Sleep disruption as cause and consequenc
Biorhythmic Interference via Controlled Sleep Oscillations 0.661 neurodegeneration Microglia-astrocyte crosstalk amplificat
Treat Glymphatic Failure by Coupling AQP4-Targeted Therapy t 0.630 neurodegeneration How can AQP4 be effectively targeted the
A lower trazodone dose of 50-100 mg nightly may be sufficien 0.580 neurodegeneration -
Restorative Sleep Induction as the Threshold Mechanism: Dose 0.545 - What is the minimum effective dose of tr
Sleep-Stage TFUS to Restore SWR-Gamma Coupling and Memory Co 0.525 alzheimers Closed-loop transcranial focused ultraso
Complement Regulator CD55/CD46 Expression Modulates Microgli 0.380 synaptic-biology What determines the selectivity of compl
Biofluid-Guided Predictive Sleep Intervention 0.000 - Sleep disruption as cause and consequenc
Sleep-Dependent Synaptic Plasticity Restoration 0.000 - Sleep disruption as cause and consequenc
Sleep Architecture Optimization via Glymphatic Pacing 0.000 - Perivascular spaces and glymphatic clear
Glymphatic Enhancement Through Controlled Sleep Depth Modula 0.000 - Sleep disruption as cause and consequenc
Metabotropic Glutamate Receptor-Based Sleep Stabilization Th 0.000 - Sleep disruption as cause and consequenc
Trauma-Induced Sleep Disruption as Therapeutic Window 0.000 - Sleep disruption as cause and consequenc

Mentioning Analyses (2)

Scientific analyses that reference this entity

What is the optimal dosage and timing of melatonin administration for AD prevent

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.735

Sleep disruption as cause and consequence of neurodegeneration

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (16)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Phenobarbital treatment efficacy study clinical intractable epilepsy 0.900 0.00 human patient and Gabra1+/-/Ga proposed N/A
Gabra1+/-/Gabrg2+/- mouse model characterization validation epilepsy with optic atrophy 0.900 0.00 Gabra1+/-/Gabrg2+/- mice proposed N/A
Optic nerve myelination analysis exploratory optic atrophy 0.880 0.00 Gabra1+/-/Gabrg2+/- mice proposed N/A
GABAA receptor subunit expression analysis exploratory epilepsy 0.850 0.00 Gabra1+/-/Gabrg2+/- mice proposed N/A
Brain Connectivity-Targeted tACS Trial in Early AD clinical Alzheimer's Disease 0.509 0.50 human postmortem brain tissue proposed $520,000
s:** - Test whether HCN1 knockout specifically in EC layer II accelera falsification Alzheimer's Disease 0.400 0.50 cell_line proposed $80,000
tACS Connectivity Trial in Early Alzheimer's clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Brain Connectivity-Targeted tACS Trial in Early AD clinical Alzheimer's Disease 0.400 0.50 mouse proposed $730,000
DLB Cognitive Fluctuation Mechanism Experiment clinical Neurodegeneration 0.400 0.50 human proposed $6,550,000
Migraine Cortical Hyperexcitability and Alzheimer's Disease Risk: Long clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Neural Oscillation Dysfunction Validation in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Sleep and Circadian Dysfunction as Driver of Neurodegeneration clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Sleep Disruption and Alzheimer's Disease — mechanism and intervention clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Non-Dopaminergic Neurotransmitter Degeneration in PD - Experiment Desi clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
A brain-to-gut signal controls intestinal fat absorption. [PMID:39261733] Lyu Q, Xue W, Liu R, Ma Q, Kasaragod VB, Nature 2024 1
Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human [PMID:37703949] Zhang Q, Forster-Gibson C, Bercovici E, Exp Neurol 2023 1
Pharmacogenetics of anxiety and depression in Alzheimer's disease. [PMID:36628952] Cacabelos R, Carril JC, Corzo L, Pego R, Pharmacogenomics 2023 1
Genetic factors in precocious puberty. [PMID:34665958] Shim YS, Lee HS, Hwang JS Clin Exp Pediatr 2022 1
Sleep drives metabolite clearance from the adult brain. [PMID:24136970] Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Th Science 2013 1
Effects of caffeine on sleep and cognition. [PMID:21531247] Snel J, Lorist MM Prog Brain Res 2011 1
Functional dissection of Timekeeper (Tik) implicates opposite roles for CK2 and [PMID:19536808] Kunttas-Tatli E, Bose A, Kahali B, Bisho Genesis 2009 1
CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the [PMID:41654970] Lu W, Kawatani K, Ren Y Alzheimers Res Ther 2026 0
Molecular brake on firing pattern transitions in MHbChAT neurons to mediate nico [PMID:41903536] Zheng ZW, Min PX, Luo YL, Mao XF, Zhang Neuron 2026 0
Estradiol modulates neuronal network hyperexcitability in select NDD risk genes. [PMID:41757108] Pruitt A, Yang L, Lee S, Balafkan N, Sea bioRxiv : the preprint server 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Prenatal alcohol exposure dysregulates the expression of clock genes and alters [PMID:41086861] Reina-Campos M, Gallego-Landin I, Medran Open biology 2025 0
Sleep-improving effect and the potential mechanism of Morus alba L. on mice. [PMID:39255910] Kong X, Zhou X, Li R, Kang Q, Hao L, Zhu Fitoterapia 2024 0
Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. [PMID:34273098] ["Oristrell J", "Oliva J", "Casado E", " Journal of endocrinological in 2022 0
Intracellular calcium homeostasis and its dysregulation underlying epileptic sei [PMID:36403388] Zhou X, Chen Z, Xiao L, Zhong Y, Liu Y, Seizure 2022 0
To beat Omicron, Delta and bird flu, Europe must pull together [PMID:34893768] Desvars-Larrive Amélie Nature 2021 0
Facilitating successful online meetings in healthcare. [PMID:33789331] Dennis Sherrod; Cecil Holland Nursing management 2021 0
Homeostatic plasticity and burst activity are mediated by hyperpolarization-acti [PMID:33547341] Rátkai A, Tárnok K, Aouad HE, Micska B, Scientific reports 2021 0
Machine learning reveals bilateral distribution of somatic L1 insertions in huma [PMID:33432196] ["Zhu X", "Zhou B", "Pattni R", "Gleason Nature neuroscience 2021 0

Debates (2)

Multi-agent debates referencing this entity

What is the optimal dosage and timing of melatonin administration for AD prevent

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

What are the mechanisms underlying sleep disruption as cause and consequence of

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning SLEEP in their description or question text

Restorative Sleep Induction as the Threshold Mechanism: Dose-Dependent REM Enhan

Score: 0.545 · unknown disease · 2026-04-26

At doses of 50-100 mg, trazodone increases slow-wave sleep continuity and REM duration, indirectly enhancing glymphatic

Sleep-Stage TFUS to Restore SWR-Gamma Coupling and Memory Consolidation

Score: 0.525 · alzheimers · 2026-04-28

H4 represents the strongest systems-neuroscience endpoint from the debate, focusing on restoring hippocampal sleep physi

Complement Regulator CD55/CD46 Expression Modulates Microglial Engulfment During

Score: 0.380 · synaptic-biology · 2026-04-27

The circadian-regulated expression of complement regulators CD55 and CD46 on synaptic membranes establishes a temporal g

Biofluid-Guided Predictive Sleep Intervention

Score: 0.000 · unknown disease · 2026-04-28

Real-time monitoring of sleep-related biofluid changes to guide personalized sleep interventions before overt neurodegen

Sleep-Dependent Synaptic Plasticity Restoration

Score: 0.000 · unknown disease · 2026-04-28

Pharmacological enhancement of sleep-dependent synaptic plasticity processes to restore the restorative functions of sle

Sleep Architecture Optimization via Glymphatic Pacing

Score: 0.000 · unknown disease · 2026-04-28

Pharmacological enhancement of slow-wave sleep phases to amplify natural glymphatic pulsations that drive CSF flow throu

Glymphatic Enhancement Through Controlled Sleep Depth Modulation

Score: 0.000 · unknown disease · 2026-04-28

Targeted transcranial stimulation or pharmacological agents that specifically enhance slow-wave sleep to maximize glymph

Metabotropic Glutamate Receptor-Based Sleep Stabilization Therapy

Score: 0.000 · unknown disease · 2026-04-28

Selective mGluR5 positive allosteric modulators to stabilize sleep-wake cycles by enhancing glutamatergic signaling duri

Trauma-Induced Sleep Disruption as Therapeutic Window

Score: 0.000 · unknown disease · 2026-04-28

Immediate post-trauma sleep optimization to prevent the cascade of sleep disruption that leads to chronic neurodegenerat